4.5 Article Proceedings Paper

Hepatic metastases in gastrointestinal stromal tumors: oncologic outcomes with curative-intent hepatectomy, resection of treatment-resistant disease, and tyrosine kinase inhibitor therapy alone

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Surgery

Outcome of 1000 Patients With Gastrointestinal Stromal Tumor (GIST) Treated by Surgery in the Pre- and Post-imatinib Eras

Michael J. Cavnar et al.

Summary: Surgery for gastrointestinal stromal tumor (GIST) in the imatinib era has resulted in prolonged overall survival compared to the pre-imatinib era. Tumor site, size, and mitotic rate in pre-imatinib era primary tumor patients are associated with survival. Imatinib treatment may benefit patients with high-risk features, particularly tumor size.

ANNALS OF SURGERY (2021)

Article Oncology

Disease-free Interval Is Associated with Oncologic Outcomes in Patients with Recurrent Gastrointestinal Stromal Tumor

Thomas L. Sutton et al.

Summary: Longer disease-free interval (DFI) exceeding 24 months in GIST patients is independently associated with higher post-recurrence survival rate and better progression-free survival rate at 10 years. DFI duration may be linked to tumor biology characteristics and treatment planning.

ANNALS OF SURGICAL ONCOLOGY (2021)

Article Surgery

Liver surgery in the multidisciplinary management of gastrointestinal stromal tumour

Ferdinando C. M. Cananzi et al.

ANZ JOURNAL OF SURGERY (2014)

Article Oncology

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. A. Eisenhauer et al.

EUROPEAN JOURNAL OF CANCER (2009)

Review Pathology

Molecular pathobiology of gastrointestinal stromal sarcomas

Christopher L. Corless et al.

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)